“national-institute-of-allergy-and-infectious-diseases” Archives

in
Entry Author Date Location
Moderna, Pfizer Protocols May Make COVID Vaccines Hard to Compare 08/07/20 National
FDA Reverses Authorization for Use of Antimalarials to Treat COVID-19 06/15/20 National
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More 05/01/20 National
Herceptin Inventors, Immunology Pioneers Take Home 2019 Lasker Awards 09/10/19 National
NIH Using Vaccines from Madison Startup FluGen in New Clinical Trial 09/19/18 Wisconsin
FluGen May Seek Funding from $12M Gates-Backed Flu Vaccine Challenge 05/01/18 Wisconsin
Ebola Outbreak a Proving Ground for Lucigen’s Rapid Diagnostic 11/03/14 Wisconsin
Gilead Following Multiple Paths Toward HIV “Functional Cure” 03/24/14 San Francisco
Enanta, No Longer Obscure, Seeks Slice of Big Hepatitis C Market 01/24/14 Boston
Inviragen, Global Health Vaccine Maker, Bought by Takeda for $35M 05/08/13 Boulder/Denver
Verdezyne Gets $1.7M Grant 10/19/09 San Diego
Cell Therapeutics Ships App to FDA, Targeted Genetics Cuts Again, Sanofi CEO Looks to Biotech & More Seattle Area Life Sciences News 06/25/09 Seattle
HIV’s “Tireless Warrior,” Anthony Fauci, Calls for Transformation of TB Research 06/18/09 Seattle
Page 1 of 1